Uterine cancer mostly refers to endometrial cancer, also known as uterine body cancer, which is one of the malignant tumors occurring in the uterus. The treatment for endometrial cancer mainly includes surgery, radiotherapy, chemotherapy and hormonal drug therapy, which can be used alone or in combination. For endometrial cancer detected in early stage, with reasonable and effective treatment, it can prevent cancer cells from spreading and metastasis, prevent recurrence, and usually can be basically cured; for advanced endometrial cancer, it is difficult to be cured, but through comprehensive treatment, plus regular follow-up after completion of treatment to determine whether there is recurrence in time, it can relieve symptoms, prolong life span and improve survival rate of patients. The prognosis of endometrial cancer is related to patient’s age, general condition, clinical-surgical-pathological staging, pathological type, tissue grading and other factors, so each person’s situation is different and the prognosis should be combined with the above factors to make a comprehensive judgment. For endometrial cancer, early detection and early treatment are necessary. Early stage patients have a better prognosis, and regular cancer prevention checkups should be conducted, especially for those with high-risk factors such as obesity, hypertension, diabetes, polycystic ovary syndrome, anovulatory uterine bleeding, unmarried, few births, delayed menopause, etc., to correctly grasp the indications of estrogen use, and to be alert to the possibility of endometrial cancer in perimenopausal menstrual disorders, irregular vaginal bleeding and postmenopausal vaginal bleeding.